Aspira Women's Health Inc.
Hedge Funds Holdings
Last updated:
Aspira Women's Health Inc.‘s stocks are currently a part of 35 hedge funds’ portfolios, which represents 3.14% of the total amount of its stocks outstanding. This makes up a total of 3.66M shares of Aspira Women's Health Inc.. Compared to the previous quarter, the number fell by -62.31% or -6.05M shares fewer. As for the holding position changes, 25.71% (9) of current hedge fund investors increased the number of shares held, 22.86% (8) of current holders sold a part of the shares held, and 2.86% (1) closed the holdings completely. 7 hedge funds are new holders of Aspira Women's Health Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding Aspira Women's Health (Q1 2016 – Q1 2023)
| Q1 2016 | 2 |
|---|---|
| Q2 2016 | 3 |
| Q3 2016 | 2 |
| Q4 2016 | 2 |
| Q1 2017 | 1 |
| Q2 2017 | 1 |
| Q3 2017 | 0 |
| Q2 2020 | 62 |
| Q3 2020 | 68 |
| Q4 2020 | 82 |
| Q1 2021 | 97 |
| Q2 2021 | 95 |
| Q3 2021 | 92 |
| Q4 2021 | 97 |
| Q1 2022 | 91 |
| Q2 2022 | 66 |
| Q3 2022 | 54 |
| Q4 2022 | 44 |
| Q1 2023 | 35 |
Hedge funds changes in Aspira Women's Health positions (Q1 2016 – Q1 2023)
| Q1 2016 | 1 | 1 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2016 | 1 | 1 | 1 | 0 | 0 |
| Q3 2016 | 1 | 1 | 0 | 2 | -2 |
| Q4 2016 | 1 | 1 | 0 | 1 | -1 |
| Q1 2017 | 0 | 0 | 1 | 1 | -1 |
| Q2 2017 | 0 | 0 | 1 | 0 | 0 |
| Q3 2017 | 0 | 0 | 0 | 1 | -1 |
| Q2 2020 | 62 | 0 | 0 | 0 | 0 |
| Q3 2020 | 15 | 31 | 10 | 9 | 3 |
| Q4 2020 | 18 | 37 | 15 | 3 | 9 |
| Q1 2021 | 24 | 27 | 28 | 9 | 9 |
| Q2 2021 | 20 | 21 | 32 | 22 | 0 |
| Q3 2021 | 14 | 32 | 24 | 17 | 5 |
| Q4 2021 | 20 | 31 | 31 | 15 | 0 |
| Q1 2022 | 12 | 22 | 36 | 18 | 3 |
| Q2 2022 | 13 | 13 | 29 | 36 | -25 |
| Q3 2022 | 8 | 8 | 15 | 19 | 4 |
| Q4 2022 | 6 | 5 | 15 | 14 | 4 |
| Q1 2023 | 7 | 9 | 8 | 1 | 10 |
Hedge funds changes in Aspira Women's Health stock options (Q1 2016 – Q1 2023)
| Q1 2016 | 0 | 0 |
|---|---|---|
| Q2 2016 | 0 | 0 |
| Q3 2016 | 0 | 0 |
| Q4 2016 | 0 | 0 |
| Q1 2017 | 0 | 0 |
| Q2 2017 | 0 | 0 |
| Q3 2017 | 0 | 0 |
| Q2 2020 | 175,000 | 0 |
| Q3 2020 | 35,000 | 62,000 |
| Q4 2020 | 195,000 | 961,000 |
| Q1 2021 | 710,000 | 982,000 |
| Q2 2021 | 101,000 | 835,000 |
| Q3 2021 | 0 | 117,000 |
| Q4 2021 | 0 | 26,000 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 33 | 0 |
| Q1 2023 | 0 | 0 |